Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Biosensors & Bioelectronics
|
September 3, 2016
A novel label-free cell-based assay technology using biolayer interferometry
D Verzijl, T Riedl, P W H I Parren, et al.
Blood Cancer Journal
|
July 26, 2012
The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
M S van der Veer, M de Weers, B van Kessel, et al.
Archives of Dermatological Research
|
November 9, 2006
In situ depletion of CD4+ T cells in human skin by Zanolimumab
L S Villadsen, L Skov, T N Dam, et al.
Scandinavian Journal of Immunology
|
July 15, 2017
CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells
M Peipp, D Wesch, H-H Oberg, et al.
Leukemia
|
October 19, 2011
Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity
C Kellner, D Hallack, P Glorius, et al.
Leukemia
|
June 5, 2012
The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells
P Glorius, A Baerenwaldt, C Kellner, et al.
Journal of Immunological Methods
|
July 16, 2011
Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate development
C Kellner, W K Bleeker, J J Lammerts van Bueren, et al.
Journal of Autoimmunity
|
June 24, 2025
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation
M D van den Beukel, L Zhang, S van der Meulen, et al.
Clinical and Experimental Immunology
|
December 20, 2019
Carbamylation reduces the capacity of IgG for hexamerization and complement activation
R Lubbers, S C Oostindie, D J Dijkstra, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Biosensors & Bioelectronics
|
September 3, 2016
A novel label-free cell-based assay technology using biolayer interferometry
D Verzijl, T Riedl, P W H I Parren, et al.
Blood Cancer Journal
|
July 26, 2012
The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
M S van der Veer, M de Weers, B van Kessel, et al.
Archives of Dermatological Research
|
November 9, 2006
In situ depletion of CD4+ T cells in human skin by Zanolimumab
L S Villadsen, L Skov, T N Dam, et al.
Scandinavian Journal of Immunology
|
July 15, 2017
CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells
M Peipp, D Wesch, H-H Oberg, et al.
Leukemia
|
October 19, 2011
Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity
C Kellner, D Hallack, P Glorius, et al.
Leukemia
|
June 5, 2012
The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells
P Glorius, A Baerenwaldt, C Kellner, et al.
Journal of Immunological Methods
|
July 16, 2011
Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate development
C Kellner, W K Bleeker, J J Lammerts van Bueren, et al.
Journal of Autoimmunity
|
June 24, 2025
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation
M D van den Beukel, L Zhang, S van der Meulen, et al.
Clinical and Experimental Immunology
|
December 20, 2019
Carbamylation reduces the capacity of IgG for hexamerization and complement activation
R Lubbers, S C Oostindie, D J Dijkstra, et al.
Page
of 1